1. Search Result
Search Result
Results for "

transformylase

" in MedChemExpress (MCE) Product Catalog:

14

Inhibitors & Agonists

8

Peptides

2

Natural
Products

3

Antibodies

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P0224
    N-Formyl-Met-Leu-Phe
    15+ Cited Publications

    fMLP; N-Formyl-MLF

    TNF Receptor Inflammation/Immunology
    N-Formyl-Met-Leu-Phe (fMLP; N-Formyl-MLF) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR). N-Formyl-Met-Leu-Ph is reported to inhibit TNF-alpha secretion.
    N-Formyl-Met-Leu-Phe
  • HY-150252A
    ATIC-IN-1 acetate
    1 Publications Verification

    Endogenous Metabolite Cancer
    ATIC-IN-1 (compound 14) acetate is an inhibitor targeting to Aminoimidazole carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase (ATIC) dimerization with a Ki value of 685 nM, whcich catalyzes de novo purine biosynthesis. ATIC dimerization is crucial for its aminoimidazole carboxamide ribonucleotide (AICAR) transformylase activity. ATIC-IN-1 acetate exhibits anti-tumor activity via reduction in cell numbers and cell division rates .
    ATIC-IN-1 acetate
  • HY-137129

    Dihydrofolate reductase (DHFR) Cancer
    10-Formyl-7,8-dihydrofolic acid is a biologically active folic acid and growth promoter. 10-Formyl-7,8-dihydrofolic acid serves as a substrate for aminoimidazolecarboxamide ribonucleotide transformylase and dihydrofolate reductase (DHFR) to support catalytic reactions (with detection wavelengths of 552 nm and 340 nm, respectively). 10-Formyl-7,8-dihydrofolic acid not only promotes the growth of leukemia cells, but also effectively reverses the growth inhibition induced by antifolate drugs under folate-deficient conditions. 10-Formyl-7,8-dihydrofolic acid can be used in the research of leukemia .
    10-Formyl-7,8-dihydrofolic acid
  • HY-135108

    Neurokinin Receptor Neurological Disease
    QWF Peptide (Compound 4a) is a substance P antagonist with an IC50 of 0.09 μM. QWF Peptide antagonizes the SP-induced contraction of isolated guinea pig trachea strips with an IC50 of 4.7 μM .
    QWF Peptide
  • HY-133157

    5-Formamidoimidazole-4-carboxamide ribotide

    DNA/RNA Synthesis Infection
    FAICAR (5-Formamidoimidazole-4-carboxamide ribotide) is a purine nucleotide and the IMP cyclohydrolase substrate of Cryptococcus neoformans ATIC. It is a key intermediate in the de novo purine synthesis pathway. FAICAR can be used in studies related to Cryptococcus neoformans infection .
    FAICAR
  • HY-P1744

    fMLFK

    Formyl Peptide Receptor (FPR) Inflammation/Immunology
    N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D281 7.32G, respectively .
    N-Formyl-Met-Leu-Phe-Lys
  • HY-P10738

    Formyl Peptide Receptor (FPR) Infection
    N-Formyl-MMYALF is a potent mitochondrial N-formyl peptide (mtFP) that has the activity of depleting calcium ions in the endoplasmic reticulum. N-Formyl-MMYALF can inhibit the FPR-1-mediated chemotactic response of polymorphonuclear leukocytes (PMNs) to bacterial peptides .
    N-Formyl-MMYALF
  • HY-P1591

    For-Nle-Leu-Phe-Nle-Tyr-Lys-OH

    Formyl Peptide Receptor (FPR) Inflammation/Immunology
    N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist .
    N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys
  • HY-150252

    Others Cancer
    ATIC-IN-1(compound 14) is an inhibitor targeting to Aminoimidazole carboxamide ribonucleotide transformylase/inosine monophosphate cyclohydrolase (ATIC) dimerization with a Ki value of 685 nM. ATIC dimerization is crucial for its aminoimidazole carboxamide ribonucleotide (AICAR) transformylase activity. ATIC-IN-1 exhibits anti-tumor activity via reduction in cell numbers and cell division rates .
    ATIC-IN-1
  • HY-P1756

    Formyl Peptide Receptor (FPR) Inflammation/Immunology
    N-Formyl-Met-Ala-Ser is a peptide, binds to formyl peptide receptors on neutrophils.
    N-Formyl-Met-Ala-Ser
  • HY-117058

    (6S)-DDATHF

    Antifolate Cancer
    LY243246 ((6S)-DDATHF), the 6S diastereomer of DDATHF, is a potent competitive inhibitor of 5’-phosphoribosylglycinamide formyltransferase (GAR transformylase). 6R- and 6S-diastereomers of DDATHF are remarkably similar and equiactive antimetabolites inhibitory to de novo purine synthesis .
    LY243246
  • HY-P10738A

    Formyl Peptide Receptor (FPR) Infection
    N-Formyl-MMYALF TFA is a mitochondrial N-formyl peptide that has the activity of depleting calcium ions in the endoplasmic reticulum. N-Formyl-MMYALF TFA can inhibit the FPR-1-mediated chemotactic response of PMNs to bacterial peptides .
    N-Formyl-MMYALF TFA
  • HY-P1591A

    For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA

    Formyl Peptide Receptor (FPR) Inflammation/Immunology
    N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA (For-Nle-Leu-Phe-Nle-Tyr-Lys-OH TFA) is a formyl peptide receptor (FPR) agonist .
    N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys TFA
  • HY-183973

    Thymidylate Synthase Inflammation/Immunology Cancer
    MTXPG5 is a long-chain Methotrexate (HY-14519) metabolite and thymidylate synthase inhibitor with a Ki of 0.047 μM. MTXPG5 inhibits 5-aminoimidazole-4-carboxamide ribonucleotide transformylase, interferes with DNA synthesis and immune cell proliferation, and inhibits pro-inflammatory cytokine production via extracellular adenosine accumulation and elevated cAMP levels. MTXPG5 can be used for the research of leukaemia and rheumatoid arthritis .
    MTXPG5

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: